SCHEMBL11116524

SCHEMBL11116524

O=C(c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1)N1CCOCC1

nearest known ligand 0.89

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.89
ALDH1A1 P00352 2/20 0.70
ALOX15 P16050 1/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
NPSR1 Q6W5P4 2/20 0.57
TP53 P04637 1/20 0.57
HPGD P15428 5/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
KDM4E B2RXH2 1/20 0.56
APP P05067 1/20 0.56
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
GAA P10253 1/20 0.55
GLA P06280 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1647854 0.89 HSD17B10 (0.72) HSD17B10ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1647420 0.85 HSD17B10 (0.70) HSD17B10ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL23067450 0.85 HSD17B10 (0.67) HSD17B10ALDH1A1ALOX15NPC1RAB9A
SCHEMBL2928667 0.82 HSD17B10 (0.69) HSD17B10ALDH1A1ALOX15SMN1; SMN2NPC1
SCHEMBL4473338 0.81 HSD17B10 (0.61) HSD17B10ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL12381279 0.80 L3MBTL3 (0.62) HSD17B10ALDH1A1HPGDKMT2AMEN1
SCHEMBL12381290 0.79 L3MBTL3 (0.61) HSD17B10ALDH1A1KDM4E
SCHEMBL1647477 0.79 HSD17B10 (0.60) HSD17B10ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL11091860 0.79 NPC1 (0.63) HSD17B10ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2932586 0.78 HSD17B10 (0.58) HSD17B10ALDH1A1SMN1; SMN2NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0115413-A1 +/- 2-(Phenethyl)-5-((3,4-methylenedioxy)-alpha-hydroxybenzyl)-pyrrolidines, pharmaceutical compositions containing them, processes for their production and intermediates therefor SYNTEX (U.S.A.) INC. (US) 1984-08-08 EP disclosed